Proteinqure

Proteinqure company information, Employees & Contact Information

Explore related pages

Related company profiles:

ProteinQure is a biotech company focused on the design of novel exotic peptides with broad therapeutic applications. Powered by atomic-level simulations and artificial intelligence, we design dynamic peptides that take drugs straight to their target – outperforming other treatment delivery systems. By daring to deliver therapeutics in a novel way we are changing the game for drug development and bringing hope to patients with previously untreatable diseases. At ProteinQure, we pride ourselves on our unique, diverse and cross-disciplinary team that brings together experts from experimental & computational biology, machine learning and software engineering.

Company Details

Employees
34
Founded
-
Address
119 Spadina Ave, 304,canada
Phone
+1 (437) 779 8504
Email
te****@****ure.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Associate jobs.
HQ
Toronto, Ontario
Looking for a particular Proteinqure employee's phone or email?

Proteinqure Questions

News

ProteinQure Receives Regulatory Clearance to Initiate Phase I Trial for PQ203 in the U.S. and Canada; Granted FDA Fast Track Designation - Business Wire

ProteinQure Receives Regulatory Clearance to Initiate Phase I Trial for PQ203 in the U.S. and Canada; Granted FDA Fast Track Designation Business Wire

PQ203 Receives Regulatory Clearance for Breast Cancer Trial - Targeted Oncology

PQ203 Receives Regulatory Clearance for Breast Cancer Trial Targeted Oncology

ProteinQure Announces First Patient Dosed in Phase I Clinical Trial of PQ203 in Advanced Metastatic Cancer - The AI Journal

ProteinQure Announces First Patient Dosed in Phase I Clinical Trial of PQ203 in Advanced Metastatic Cancer The AI Journal

ProteinQure Closes $11M in Series A Financing - FinSMEs

ProteinQure Closes $11M in Series A Financing FinSMEs

ProteinQure to Present Data on PQ203, a Novel Peptide-Drug Conjugate for Triple Negative Breast Cancer, at 2024 San Antonio Breast Cancer Symposium - Yahoo Finance

ProteinQure to Present Data on PQ203, a Novel Peptide-Drug Conjugate for Triple Negative Breast Cancer, at 2024 San Antonio Breast Cancer Symposium Yahoo Finance

ProteinQure nabs $11M to bring AI-designed peptide-drug conjugate to the clinic - FirstWord Pharma

ProteinQure nabs $11M to bring AI-designed peptide-drug conjugate to the clinic FirstWord Pharma

Proteinqure’s PQ-203 cleared to enter clinic in US and Canada - BioWorld MedTech

Proteinqure’s PQ-203 cleared to enter clinic in US and Canada BioWorld MedTech

Medtech AI startups ProteinQure and AssistIQ each close Series A rounds - BetaKit

Medtech AI startups ProteinQure and AssistIQ each close Series A rounds BetaKit

ProteinQure Raises Series A Financing to Advance First AI-Designed Peptide Therapeutic into Clinical Trials - BioSpace

ProteinQure Raises Series A Financing to Advance First AI-Designed Peptide Therapeutic into Clinical Trials BioSpace

ProteinQure Collaborates with AstraZeneca to Design Novel Peptide Therapeutics - Business Wire

ProteinQure Collaborates with AstraZeneca to Design Novel Peptide Therapeutics Business Wire

ProteinQure raises $5.2 million CAD for protein-focused drug design platform - BetaKit

ProteinQure raises $5.2 million CAD for protein-focused drug design platform BetaKit

Top Proteinqure Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant